MAIA Biotechnology | 10-Q: Quarterly report

SEC announcementMay 15 04:20 · Announcements

MAIA Biotechnology Unveils New Business Overview Presentation

TipRanksMay 8 05:32

MAIA Biotechnology Shares Hit 52-Week High After Director Stock Purchase

By Chris Wack MAIA Biotechnology shares hit their 52-week high Monday after it said that independent director Stan Smith made an individual purchase of 147,000 shares, and warrants for 147,000 shares

WSJApr 30 01:04

NYSE American New 52-Week Highs And Lows

New Highs 7 COMPANY SYMBOL HIGH VOLUME ------- ------ ---- ------ Air Industries Group AIRI 7.24 71,596 Ar

Dow JonesApr 29 22:20

MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement

Dr. Smith has participated in every MAIA funding round CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc., (NYSE American: MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company de

BusinesswireApr 29 20:08

Maia Biotechnology Insider Bought Shares Worth $299,409, According to a Recent SEC Filing

Stan Smith, Director, on April 25, 2024, executed a purchase for 147,492 shares in Maia Biotechnology (MAIA) for $299,409. Following the Form 4 filing with the SEC, Smith has control over a total of 1

MT NewswiresApr 27 05:37